A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Cumberbatch MG, Cox A, Teare D, Catto JW. Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol. 2015;1:1282–1290.
   PubMed Web of Science ®Google Scholar
• Felsenstein KM, Theodorescu D. Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy. Nat Rev Urol. 2018;15:92–111.
   PubMed Web of Science ®Google Scholar
• Santoni G, Morelli MB, Amantini C, Battelli N. Urinary markers in bladder cancer: an update. Front Oncol. 2018;8:362.
   PubMed Web of Science ®Google Scholar
• Nitta M, Kuroda S, Nagao K, et al. Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study. Jpn J Clin Oncol. 2019;50(1):73–79.
   Web of Science ®Google Scholar
• Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 2017;27:673–684.
   PubMed Web of Science ®Google Scholar
• Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243:206–214.
   PubMed Web of Science ®Google Scholar
• Broz P, Pelegrín P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20:3.
   PubMed Web of Science ®Google Scholar
• Ding J, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111–116.
   PubMed Web of Science ®Google Scholar
• Feng S, Fox D, Man SM. Mechanisms of gasdermin family members in inflammasome signaling and cell death. J Mol Biol. 2018;430:3068–3080.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen X, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res. 2018;28:9–21.
   PubMed Web of Science ®Google Scholar
• Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26:99–114.
   PubMed Web of Science ®Google Scholar
• Dupaul-Chicoine J, Yeretssian G, Doiron K, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 2010;32:367–378.
   PubMed Web of Science ®Google Scholar
• Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13:110.
   PubMed Web of Science ®Google Scholar
• Xi G, Gao J, Wan B, et al. GSDMD is required for effector CD8 T cell responses to lung cancer cells. Int Immunopharmacol. 2019;74:105713.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415–420.
   PubMed Web of Science ®Google Scholar
• Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19:197–214.
   PubMed Web of Science ®Google Scholar
• Xia X, Wang X, Cheng Z, et al. The role of pyroptosis in cancer: Pro-Cancer or Pro-”Host”? Cell Death Dis. 2019;10:650.
   PubMed Web of Science ®Google Scholar
• Wang B, Yin Q. AIM2 inflammasome activation and regulation: a structural perspective. J Struct Biol. 2017;200:279–282.
   PubMed Web of Science ®Google Scholar
• Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6–21.
   PubMed Web of Science ®Google Scholar
• Zhou M, Liu Z, Zhao Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of proapoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010;285:21496–21507.
   PubMed Web of Science ®Google Scholar
• Shi XB, Xue L, Yang J, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA. 2007;104:19983–19988.
   PubMed Web of Science ®Google Scholar
• Zhu J, Tang B, Lv X, et al. Transcriptomic aberrations and revealing clinical relevance as diagnostic and prognostic biomarker in Hepatocellular Carcinoma. Front Oncol. 2020;10:519180.
   PubMed Web of Science ®Google Scholar
• Zhu L, Yan D, Chen Y, Chen S, Chen N, Han J. The identification of autophagy-related genes in the prognosis of oral squamous cell carcinoma. Oral Dis. 2020;26:1659–1667.
   PubMed Web of Science ®Google Scholar
• Konishi M, Erdem SS, Weissleder R, Lichtman AH, McCarthy JR, Libby P. Imaging Granzyme B activity assesses immune-mediated myocarditis. Circ Res. 2015;117:502–512.
   PubMed Web of Science ®Google Scholar
• Wu CH, Li J, Li L, et al. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J Extracell Vesicles. 2019;8:1588538.
   PubMed Web of Science ®Google Scholar
• Salama P, Phillips M, Platell C, Iacopetta B. Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion. Histopathology. 2011;59:207–215.
   PubMed Web of Science ®Google Scholar
• Chiusolo V, Jacquemin G, Yonca Bassoy E, et al. Granzyme B enters the mitochondria in a Sam50-, Tim22- and mtHsp70dependent manner to induce apoptosis. Cell Death Differ. 2017;24:747–758.
   PubMed Web of Science ®Google Scholar
• Jacquemin G, Margiotta D, Kasahara A, et al. Granzyme B-induced mitochondrial ROS are required for apoptosis. Cell Death Differ. 2015;22:862–874.
   PubMed Web of Science ®Google Scholar
• Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368:1–15.
   Web of Science ®Google Scholar
• Kumari P, Russo AJ, Shivcharan S, Rathinam VA. AIM2 in health and disease: inflammasome and beyond. Immunol Rev. 2020;297:83–95.
   PubMed Web of Science ®Google Scholar
• Choubey D. Absent in melanoma 2 proteins in the development of cancer. Cell Mol Life Sci. 2016;73:4383–4395.
   PubMed Web of Science ®Google Scholar
• Fujita T, Reis LF, Watanabe N, Kimura Y, Taniguchi T, Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA. 1989;86(24):9936–9940.
   PubMed Web of Science ®Google Scholar
• Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 1994;263:1612–1615.
   PubMed Web of Science ®Google Scholar
• Bouker KB, Skaar TC, Riggins RB, et al. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis. 2005;26(9):1527–1535.
   PubMed Web of Science ®Google Scholar
• Man SM, Karki R, Malireddi RK, et al. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol. 2015;16(5):467–475.
   PubMed Web of Science ®Google Scholar
• Karki R, Sharma BR, Lee E, et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020;5:1–13.
   Web of Science ®Google Scholar
• Stiewe T. The p53 family in differentiation and tumorigenesis. Nat Rev Cancer. 2007;7(3):165–168.
   PubMed Web of Science ®Google Scholar
• Nekulova M, Holcakova J, Coates P, Vojtesek B. The role of p63 in cancer, stem cells and cancer stem cells. Cell Mol Biol Lett. 2011;16(2):296–327.
   PubMed Web of Science ®Google Scholar
• Gonfloni S, Caputo V, Iannizzotto V. P63 in health and cancer. Int J Dev Biol. 2015;59(1–3):87–93.
   PubMed Web of Science ®Google Scholar
• Pflaum J, Schlosser S, Muller M. p53 family and cellular stress responses in cancer. Front Oncol. 2014;4:285.
   PubMedGoogle Scholar
• Conde E, Angulo B, Redondo P, et al. The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung. PLoS One. 2010;5(8):e12209.
   PubMed Web of Science ®Google Scholar
• Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope. 2004;114(12):2063–2072.
   PubMed Web of Science ®Google Scholar
• Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8(2):494–501.
   PubMed Web of Science ®Google Scholar
• McKeon FD. P63 and p73 in tumor suppression and promotion. Cancer Res Treat. 2004;36(1):6–12.
   PubMedGoogle Scholar
• Somerville TDD, Xu Y, Miyabayashi K, et al. TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma. Cell Rep. 2018;25(7):1741–1755.
   PubMed Web of Science ®Google Scholar
• Feng X. Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene. 2005;350:1–13.
   PubMed Web of Science ®Google Scholar
• Al-Lamki RS, Sadler TJ, Wang J, et al. Tumor necrosis factor receptor expression and signaling in renal cell carcinoma. Am J Pathol. 2010;177:943–954.
   PubMed Web of Science ®Google Scholar
• Croft M, Benedict CA, Ware CF. Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov. 2013;12:147–168.
   PubMed Web of Science ®Google Scholar
• McDonald C, Chen FF, Ollendorff V, et al. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. J Biol Chem. 2005;280:40301–40309.
   PubMed Web of Science ®Google Scholar
• Kanneganti TD, Lamkanfi M, Núñez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27:549–559.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang H, Liu LX, et al. NOD2 contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and inflammation. Life Sci. 2016;149:10–17.
   PubMed Web of Science ®Google Scholar
• Du P, Fan B, Han H, et al. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int. 2013;84:265–276.
   PubMed Web of Science ®Google Scholar
• Fritsch M, Günther SD, Schwarzer R, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575:683–687.
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood. 2004;104:2840–2848.
   PubMed Web of Science ®Google Scholar
• Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol. 2005;174:1783–1786.
   PubMed Web of Science ®Google Scholar
• Cao X, Cai SF, Fehniger TA, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007;27:635–646.
   PubMed Web of Science ®Google Scholar
• Loebbermann J, Thornton H, Durant L, et al. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012;5:161–172.
   PubMed Web of Science ®Google Scholar
• Saito T, Nishikawa H, Wada H, et al. FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat Med. 2016;22:679–684.
   PubMed Web of Science ®Google Scholar